Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-03-23 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −7,790 179,170
2021-03-19 ROBINS CHAD M CEO and Chairman Sale −4,900 $41.96 $206K 1,763,561
2021-03-19 ROBINS CHAD M CEO and Chairman Sale −100 $42.48 $4K 1,763,461
2021-03-18 Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx Option exercise +16,052 $22.55 $362K 25,210
2021-03-18 Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx Sale −8,342 $43.04 $359K 16,868
2021-03-18 Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx Sale −5,971 $43.83 $262K 10,897
2021-03-18 Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx Sale −1,739 $45.32 $79K 9,158
2021-03-18 Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx Option exercise · Stock Option (Right to Buy) −16,052 108,948
2021-03-18 ROBINS CHAD M CEO and Chairman Sale −1,926 $41.90 $81K 1,771,535
2021-03-18 ROBINS CHAD M CEO and Chairman Sale −2,604 $42.81 $111K 1,768,931
2021-03-18 ROBINS CHAD M CEO and Chairman Sale −470 $43.78 $21K 1,768,461
2021-03-17 OWEN KATEY EINTERZ Director Grant or award +4,443 4,443
2021-03-17 OWEN KATEY EINTERZ Director Grant or award · Stock Option (Right to Buy) +11,109 11,109
2021-03-17 ROBINS CHAD M CEO and Chairman Sale −1,901 $43.22 $82K 1,776,560
2021-03-17 ROBINS CHAD M CEO and Chairman Sale −1,295 $44.03 $57K 1,775,265
2021-03-17 ROBINS CHAD M CEO and Chairman Sale −1,804 $45.25 $82K 1,773,461
2021-03-17 Trigg Leslie Director Grant or award +4,443 4,443
2021-03-17 Trigg Leslie Director Grant or award · Stock Option (Right to Buy) +11,109 11,109
2021-03-16 GRIFFIN MICHELLE RENEE Director Option exercise +1,500 $7.80 $12K 3,004
2021-03-16 GRIFFIN MICHELLE RENEE Director Sale −1,500 $47.00 $71K 1,504

Page 52 of 120 · 2,386 trades